NRX Pharmaceuticals (NRXP) Change in Taxes (2018 - 2020)
NRX Pharmaceuticals (NRXP) posted quarterly Change in Taxes of -$17841.0 for Q4 2020, down 9.38% year-over-year from -$19687.7 in Q1 2020, and down 127.08% quarter-over-quarter from $65887.0 in Q3 2020.
NRX Pharmaceuticals (NRXP) Change in Taxes (2018 - 2020) Analysis & Trends
NRX Pharmaceuticals (NRXP) has reported Change in Taxes for 3 consecutive years, with -$17841.0 the latest figure, recorded in Q4 2020.
- In Q4 2020, Change in Taxes fell 9.38% year-over-year to -$17841.0; the TTM figure through Mar 2021 stood at -$20986.0 (up 53.24% YoY), while the FY2020 annual figure was -$17841.0, down 9.38% from the prior year.
- Change in Taxes declined to -$17841.0 in Q4 2020 per NRXP's latest filing, from $65887.0 in the prior quarter.
- Across five years, Change in Taxes topped out at $65887.0 in Q3 2020 and bottomed at -$69032.0 in Q2 2020.
- Historically, Change in Taxes has averaged $3107.8 across 3 years, with a median of $3630.0 in 2018.
- On a YoY basis, Change in Taxes climbed as much as 670.74% in 2019 and fell as far as 342.79% in 2019.
- NRX Pharmaceuticals' Change in Taxes stood at $48052.0 in 2018, then plunged by 133.94% to -$16311.0 in 2019, then decreased by 9.38% to -$17841.0 in 2020.
- Business Quant data shows NRXP's Change in Taxes at -$17841.0 in Q4 2020, $65887.0 in Q3 2020, and -$69032.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | NRX Pharmaceuticals | 132.53 Mn | 105.83 Mn | 426,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -17,841.00 |
| Dec 31, 2020 | -17,841.00 |
| Sep 30, 2020 | 65,887.00 |
| Sep 30, 2020 | 65,887.00 |
| Jun 30, 2020 | -69,032.00 |
| Jun 30, 2020 | -69,032.00 |
| Mar 31, 2020 | 3,145.00 |
| Mar 31, 2020 | 3,145.00 |
| Dec 31, 2019 | -16,311.00 |
| Dec 31, 2019 | -16,311.00 |
| Jun 30, 2019 | -31,716.00 |
| Jun 30, 2019 | -31,716.00 |
| Mar 31, 2019 | 31,716.00 |
| Mar 31, 2019 | 31,716.00 |
| Sep 30, 2018 | 48,052.00 |
| Sep 30, 2018 | 48,052.00 |
| Jun 30, 2018 | 13,063.00 |
| Jun 30, 2018 | 13,063.00 |
| Mar 31, 2018 | 4,115.00 |
| Mar 31, 2018 | 4,115.00 |